Combining the concepts of synthetic symmetrization with the approach of engineering metal-binding sites, we have developed a new crystallization methodology termed metal-mediated synthetic symmetrization. In this method, pairs of histidine or cysteine mutations are introduced on the surface of target proteins, generating crystal lattice contacts or oligomeric assemblies upon coordination with metal. Metal-mediated synthetic symmetrization greatly expands the packing and oligomeric assembly possibilities of target proteins, thereby increasing the chances of growing diffraction-quality crystals. To demonstrate this method, we designed various T4 lysozyme (T4L) and maltose-binding protein (MBP) mutants and cocrystallized them with one of three metal ions: copper (Cu 21 ), nickel (Ni 21 ), or zinc (Zn 21 ). The approach resulted in 16 new crystal structures-eight for T4L and eight for MBP-displaying a variety of oligomeric assemblies and packing modes, representing in total 13 new and distinct crystal forms for these proteins. We discuss the potential utility of the method for crystallizing target proteins of unknown structure by engineering in pairs of histidine or cysteine residues. As an alternate strategy, we propose that the varied crystallization-prone forms of T4L or MBP engineered in this work could be used as crystallization chaperones, by fusing them genetically to target proteins of interest.
Introduction
A common bottleneck in protein X-ray crystallography is the ability to grow diffraction-quality crystals. Although high-throughput robotics now makes it possible to screen vast numbers of crystallization conditions, some proteins remain recalcitrant to crystallization. Many approaches have been developed to improve the success rate for crystallization, for example, systematically truncating the target protein, 1,2 methylating the lysine residues, 3, 4 removing post-translational modifications, [5] [6] [7] screening homologues of the target protein for crystallization, 8, 9 fusing the target protein to a carrier protein, [10] [11] [12] [13] crystallizing racemic mixtures of the target protein, [14] [15] [16] [17] [18] [19] [20] and cocrystallizing the target protein with antibodies or other binding proteins. [21] [22] [23] A number of those methods have been reviewed. 24 Recently, rational mutagenesis of protein surface residues has been proposed to improve the crystallizability of target proteins, including methods referred to as ''surface entropy reduction'' (SER) 25 and ''synthetic symmetrization'' (or crystal lattice engineering). [26] [27] [28] The SER method typically replaces solvent-exposed, flexible amino acids, such as Lys, Glu, and Gln, with less flexible residues, such as Ala. It has been successfully used for several protein targets, [29] [30] [31] and a web-based server has been created to suggest suitable mutation sites in any given protein sequence. 30 Synthetic symmetrization involves introducing into the surface of a protein specific motifs likely to drive symmetric self-association. Motivation for the approach derives in part from the observation that protein oligomers tend to crystallize in space groups that support the point group symmetry of the oligomer. 26 In such cases, some of the contacts required to establish a crystal lattice are essentially built in to the oligomer, meaning that fewer fortuitous contacts are required. 16 The general strategy is also amenable to variation; different modes of engineered oligomerization lead to distinctly different opportunities for crystallization. One method already demonstrated for synthetically dimerizing a protein is to introduce a single cysteine on the surface and then form an intermolecular disulfide bond. That method was applied first to crystallize bacteriophage T4 lysozyme (T4L) in several new crystal forms 26 and then to crystallize an enzyme of previously unknown structure. 27 In a parallel strategy (alternately coined crystal lattice engineering), a series of surface-exposed helix residues were mutated to leucine to promote dimerization by way of an intermolecular leucine zipper 28 ; a subsequent application of that approach produced crystals by way of heterotypic interactions between the engineered half-leucine zipper and a distinct surface region from another protein molecule, rather than by way of a symmetric self-association. 32 Despite the successes demonstrated so far by the disulfide-and leucine-zipper-based approaches to synthetic symmetrization, they suffer from a limited type of symmetric association; both are designed to produce dimers.
It is known that metals play a very important role in oligomerization and crystallization of proteins. [33] [34] [35] For example, in the high-resolution crystal structure of truncated alphaA crystallin, 36 a zincbinding motif is formed by three chains, and zinc promotes protein oligomerization and crystallization. The compound tetrathiomolybdate, used in the treatment of copper metabolism disorders, reacts with the copper binding metallochaperone, Atx1, forming a stable complex. 37 The crystal structure of this complex reveals a trimer of Atx1 molecules mediated through the bound tetrathiomolybdate molecule. Tezcan and coworkers [38] [39] [40] [41] [42] have studied metaldirected protein self-assembly on the model protein, cytochrome b 562 , focusing primarily on the evolution of metal coordination in protein folds and complexes. Their work has shown that by introducing histidine mutations on the alpha helical surface of cytochrome b 562 , the protein can oligomerize to form dimers to tetramers, all of which are mediated through metal binding. Furthermore, the metals present within a protein crystal can provide the experimental phases needed for its structure determination. 43 Although the incorporation of selenomethionine into proteins has become a standard method for exploiting anomalous scattering information, 44 natural metal-binding sites containing copper, iron, nickel, cobalt, or zinc atoms have also been utilized for protein structure determination via anomalous dispersion (see Refs. 45-49 and references therein).
Here, we propose a new crystallization methodology, termed metal-mediated synthetic symmetrization, which combines the idea of synthetic symmetrization with strategies-following work by Tezcan et al. 42 -for engineering metal-binding sites at protein interfaces. This method has the potential to produce a variety of new crystal forms by introducing new contacts between protein molecules in the lattice through metal binding interactions, thereby increasing the chances of obtaining diffraction-quality crystals. We demonstrate the applicability of metal-mediated symmetrization using two proteins commonly used as fusion partners for crystallization trials: T4L and maltose-binding protein (MBP). We discuss potential advantages of this method over current approaches and ways to use the method on proteins of unknown structure, through either direct mutations on the target protein or fusion of the target protein to metal-site mutants of T4L or MBP, which could serve as crystallization chaperones.
Results

Rationale and design of mutations
On the basis of previous studies regarding natural or engineered metal-binding sites, we rationalized that mutations of solvent-exposed residue pairs i and i þ 4 of a helix [50] [51] [52] [53] or i and i þ 3 of a helixloop 37 to a pair of either histidine or cysteine residues would induce homooligomeric assemblies upon incubation with metal. Specifically, we predicted the metal site within these assemblies to take on a tetrahedral or octahedral coordination, in which the mutated histidines or cysteines among the molecules participate in the metal coordination. Such coordination geometries are commonly found in proteins 33, 54 and have been engineered previously. [37] [38] [39] [40] [41] [42] On the basis of the crystal structures of T4L and MBP in each protein, we chose three pairs of solvent-accessible residues that are located close to the ends of helices ( Fig. 1 ). The introduction of metal-binding sites near the ends of helices, compared with sites in the middle of helices, was expected to cause fewer steric clashes and allow greater coordination possibilities among molecules. In both T4L and MBP, the mutations were chosen to be distant from the C-terminus, to avoid potential interference with a fusion protein Laganowsky et al. that might be attached. The determination of which residues are on the surface-exposed side of a helix was straightforward in our test experiments with T4L and MBP, whereas this represents a challenge when the structure is unknown. A recent application of disulfide-based synthetic symmetrization 27 illustrates the use of sequence alignments and bioinformatics tools to make reasonable choices for engineering residues on the sides of helices.
T4L and MBP mutants-most containing two mutations and one containing four mutations (summarized in Table I )-were expressed, purified, and subjected to cocrystallization in the presence of either copper (Cu 2þ ), nickel (Ni 2þ ), or zinc (Zn 2þ ). The ratio of metal to protein was $1.5 to 1. In some cases, the addition of metal induced slight precipitation of the protein-metal solution that could be reversed by the addition of EDTA. However, no additional purification step, besides filtration through a 0.22 lm membrane, was performed once the metal was added (see Methods for details). Crystallization was carried out using standard commercial crystallization screens (typically only three to four 96-well experiments). For all of the mutant constructs, crystals formed in a variety of conditions within 1 week, and in some cases within 2 h, of setting up crystal screens. All structures were solved from crystals mounted from preliminary screens without any further optimization (Supporting Information Table 3 ).
T4L histidine mutants
For T4L, we created two double-histidine mutants, T4L 76H/80H and T4L 61H/65H , and one quadruple-histidine mutant, T4L 61H/65H/76H/80H , chosen to emulate the engineering design by Tezcan et al. 33 in which four histidine mutations are introduced as two pairs of proximal residues in a long helix. Crystallization of these mutants with the various metals resulted in eight crystal structures (Table I) , which represent six distinct crystal forms; in some mutants, nickel and copper produced similar metal-binding sites and crystal packing arrangements. The crystal forms obtained were all different from those observed before for T4L. 55 The molecular structures and crystal packing diagrams are shown in Figures 2 and 3 , and crystallographic statistics are shown in Supporting Information Table 1 .
Different combinations of mutations and metals led to various oligomeric forms of T4L. The protein can form either dimers [ Fig. 2 (Table I) . However, in all of the cases where this occurs, the neighboring free histidine is in a p stacking arrangement with the coordinating histidine [ Fig. 2(b-d) ], indicating it may be necessary for the coordination. Finally, not all the T4L molecules in the asymmetric unit are coordinated by the metals. In two cases, a noncoordinated molecule is present Figure 1 . Surface residues of T4 lysozyme (T4L) and maltose-binding protein (MBP) selected for mutations. (a) T4L is represented as a cartoon (blue). Three pairs of residues are labeled (red, yellow and green), each corresponding to one doubleresidue mutant: D61/K65 to histidines, R125/E128 to cysteines, R76/R80 to either histidines or cysteines in two different constructs. A quadruple histidine mutant for D61/K65/R76/R80 was also made. (b) MBP is represented as a cartoon (orange). Three pairs of residues are labeled (green, blue and purple), each corresponding to one double histidine mutant. All selected pairs are three or four residues apart and are close to the ends of helices. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] [ Fig. 2(c,d) ]. The variations in metal site geometry and protein oligomerization enable the numerous new crystal forms observed here for T4L (Table I and Fig. 3 ).
MBP histidine mutants
To demonstrate that this methodology applies not only to T4L but also to a second protein, MBP, we prepared three double-histidine mutants of MBP -MBP 216H/220H , MBP 26H/30H , and MBP 310H/314H -and crystallized them in the presence of metals (Table I) The four histidine mutant, T4L 61H/65H/76H/80H , also forms a trimer. The copper binding site is formed by the mutated histidine, H61, located on a threefold crystallographic axis. Three other protein molecules in the asymmetric unit, not bound to copper ions, are also shown (light yellow, light orange and light red). (e) The double histidine mutant, T4L 76H/80H , also forms a hexameric ring structure mediated by three zinc atoms. The zinc binding sites are formed by two mutated histidine residues, H76/H80, from two neighboring molecules. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
from the P6 1 crystal form obtained with wild-type MBP and, therefore, represent new packing modes driven by metal coordination.
T4L cysteine mutants
Considering that cysteine residues are also commonly found in coordination with metals-zinc finger proteins being a particularly well-studied case 54,56 -we explored whether cysteine mutations could also be used for metal-mediated symmetrization. We generated two double-cysteine mutants of T4L: T4L 76C/80C and T4L 125C/128C ( Fig. 6 and Supporting Information Table 1) following the design of an i and i þ 3 mutation at a helix-loop. The T4L 125C/128C mutant was inspired by the crystal structure of copper-binding Atx1 in complex with tetrathiomolybdate and copper, in which natural Cys15 and Cys18 of Atx1 participate in a complex metal binding network. 37 Both mutants were purified in the presence of 1 mM dithiothreitol (DTT) to prevent cysteine oxidation, and crystallization was carried out in the presence of zinc. Interestingly, T4L 125C/128C crystallized as a trimer mediated by a novel multinuclear zinc sulfur cluster, which to our knowledge has not been reported previously [ Fig.  6 (a) and Supporting Information Fig. 1 ]. Four zinc atoms form a tetrahedron with six sulfur atomstwo from each protein-coordinating from six edges, forming an adamantane-like cage. The zinc sulfur cluster is reminiscent of the copper (Cu 1þ ) sulfur cluster stabilized by Atx-1 and tetrathiomolybdate in anaerobic conditions. 37 The second double cysteine mutant, T4L 76C/80C , crystallized in more than 60% of the crystallization conditions from an initial screen, and some crystals diffracted to $1.5 Å without any further optimization. The structure of this mutant revealed a D 2 tetramer covalently linked by four di-sulfide bonds [ Fig. 6(b) ]. The tetramer is constituted by two dimers that have similar structures to the copper-bound T4L 76H/80H [ Fig. 2(a) ]. The disulfide bonds are all homotypic, with the two Cys 76 -Cys 76 bonds lying on one dyad axis of symmetry and the two Cys 80 -Cys 80 bonds lying on one of the other dyad axes. Surprisingly, no metal ions were observed in the electron density, although zinc ions were added to the crystallization drops. For both double cysteine mutants of T4L, the crystal packing modes are novel ( Fig. 7) , although in the second case, there was no mediation through zinc.
Discussion
In this study, we demonstrate a crystallization method that combines the concept of synthetic symmetrization with the approach of engineering metal binding sites. We generated several different double or quadruple histidine mutants of proteins T4L and MBP, which were chosen in part for their prior use as fusion proteins. On incubating these constructs (Table I) . Moreover, we crystallized two different double cysteine mutants of T4L with added zinc ions, and obtained two further distinct crystal forms exhibiting more complex packing arrangements, in one case based on direct disulfide bonding rather than metal-mediated interactions.
We obtained crystals with new symmetry and packing from all the mutation pairs we tested. Some mutants crystallized with great ease and variety. For example, MBP 216H/220H and T4L 61H/65H/76H/80H could be crystallized in many different forms, depending on the crystallization condition and the type of metal. Crystals having the same unit cell dimensions and symmetry as the wild-type protein (P3 2 21 for T4L and P6 1 for MBP) were also sometimes obtained, but at a relatively low rate (less Table 3 ) shows that conditions that facilitated metalmediated oligomeric assembly tended to either have high concentrations of salt or polyethylene glycol of various molecular weights.
than 1/3 of the time). Analysis of the crystallization conditions for all mutants (Supporting Information
The metal ions were incorporated into the crystal lattice in different ways in different crystals. In a number of structures, the metal fell on a crystallographic axis (Table I ), suggesting that the metalinduced homooligomeric assembly helped drive lattice formation. This is especially apparent in the polymeric assemblies of MBP 216H/220H and MBP 26H/30H in the presence of zinc (Fig. 5 ), in which metal coordination generates helical arrangements of subunits compatible with crystal symmetry. Both types of situation support the notion that symmetrized oligomers may gain an advantage over asymmetric monomers in crystal formation. We note that in all the crystal structures obtained, despite the variety of protein oligomeric states induced, that generally the individual metal ions added were coordinated by two subunits. We also observed that in slightly more than half of the structures, only one of the two introduced histidines participated in the coordination. In those cases, natural surface residues, usually Glu or Asp, or solvent molecules were involved in metal binding instead. This suggests the possibility in future work of combining Glu and Asp with single or double His mutations for metalmediated synthetic symmetrization.
The oligomeric protein arrangements observed by metal-mediated symmetrization were highly variable. It is likely that even greater diversity could have been realized through additional investigations. For several constructs, there were too many favorable leads from initial crystallization trials to permit a complete characterization of all the possible crystal forms. Furthermore, other experimental variables that might have produced additional crystal forms were not investigated. The relative concentration of metal ions was held fixed in our experiments, although this variable might be expected to influence the oligomeric modes of metalmediated protein association.
Polymorphic assembly behavior was also observed under different crystallization conditions for some individual combinations of protein constructs and metals. This was evident in the multiple structures of T4L 61H/65H/76H/80H with copper, for example, in which slight variations in the crystallization conditions (Supporting Information Table 3 ) led to outcomes in which the geometry of the metal coordination by T4L molecules varied from square planar to tetrahedral [Table I and Fig. 2(b,d) ]. In such cases, alternate metal-driven protein arrangements may be favored by slightly different solution conditions, or by different crystal packing arrangements. The likelihood that multiple distinct arrangements coexist in solution in some cases raises the possibility that heterogeneity could hinder crystallization. However, the multitude of our successful crystallization results, including multiple distinct forms from some individual combinations of protein construct and metal ion, argues otherwise. The reversibility of metal coordination probably has a positive effect in this regard, making it possible for favorable crystal packing arrangements to drive otherwise heterogeneous mixtures into specific, well-ordered crystal forms. Furthermore, the coordination geometries of the metal sites were often slightly distorted (Table  I ), suggesting that flexibility in metal coordination could also help enable the formation of well-ordered crystal packing arrangements.
Another potential advantage of metal-mediated synthetic symmetrization is the phasing power introduced by metals. The metal sites are well defined in most of our structures (Supporting Information  Table I and II), and anomalous signals were observed for most of them, despite that the data were not collected using an X-ray wavelength close to the absorption edge for the metals introduced (Supporting Information Fig. 1 ). For the T4L 125C/128C mutant, we confirmed that experimental phases could be obtained using the anomalous scattering from the zinc atoms (Supporting Information Fig. 1 ). By using synchrotron radiation tuned to the optimal wavelength, we anticipate that it will be generally possible to obtain diffraction phases from crystals grown by the metal-mediated symmetrization approach.
On the basis of our findings, we propose that one could utilize the concept of metal-mediated synthetic symmetrization to crystallize more difficult protein targets that have eluded crystallization using traditional methodologies. Figure 8 summarizes the ''rational mutagenesis of surface residues'' methods that have been developed to facilitate protein crystallization. In contrast to previously proposed methods, our approach allows the formation of oligomers in diverse arrangements and symmetries, giving rise to greatly expanded opportunities to grow diffraction-quality crystals. The flexibility of our approach also allows it to be potentially combined with methods such as SER in which high-entropy surface residues can be mutated.
We propose two variations by which the approach could be used to promote the crystallization of new target proteins: (i) crystallizing fusion constructs in which a target protein is fused to the various engineered forms of T4L or MBP described here, or (ii) directly crystallizing a target protein after mutating pairs of surface residues to histidine or cysteine. The first approach is based on the observation that both T4L and MBP have been successfully used to crystallize otherwise difficult proteins, including membrane proteins and amyloid proteins. 10, [57] [58] [59] [60] [61] The mutation pairs characterized in this study could be readily used to increase the chance of getting crystals. The crystal packing arrangements of such fusion proteins would depend on surface properties of the target protein and would therefore likely be different from the structures presented here. In the second, direct approach, positions for making mutation pairs in a target protein would be chosen based on predictions of secondary structure and surface exposure, or based on a homology model, when available. Double histidine or cysteine mutations are preferably introduced close to the ends of a helix (Fig. 1) . For long helices, two histidine pairs can be introduced at both ends. The spacing between the two histidines are preferably i and i þ 4, and for cysteines either i and i þ 3 or i and i þ 4. Theoretically, histidine mutations should have a broader application, because they will not interfere with native cysteines. Although additional purification of oligomeric species after metal addition was not necessary for success in our studies, this step might be useful in confirming metal-mediated assembly and optimizing the chances of success with more difficult protein targets.
Considering that it is easy to introduce double mutations, and all the crystals in this study were solved directly from robotic screens without any optimization, one could apply the approach relatively easily to generate and test several varied constructs for a given protein of interest. Such an approach could prove valuable for crystallizing asymmetric proteins or protein complexes that have eluded traditional crystallization methodologies.
Methods
T4L plasmid construction
Cysteine-less T4L (a kind gift from Mark Fleissner and Wayne Hubbell at UCLA), residues 1-162, was PCR amplified with Platinum Taq Polymerase (Invitrogen, Carlsbad, CA). The N-terminal primers contained a six base pair overhang, NdeI restriction site, TEV protease cleavage site, and a short linker of residues GP to aid TEV protease cleavage. The C-terminal primer contained a stop codon, XhoI restriction site, and a three base pair overhang. The PCR product was agarose gel purified and extracted using the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA). Purified PCR product and pET28b (Novagen, Gibbstown, NJ) were digested with NdeI and XhoI according to manufacturer protocol (New England Biolabs, Ipswich, MA). Digested pET28b and T4L products were gel purified and extracted (as described above). DNA concentrations were determined using BioPhotometer UV/VIS Photometer (Eppendorf, Westbury, NY). The vector pET28 and T4L were ligated using the Quick Ligation Kit (New England Biolabs, Ipswich, MA) according to manufacturer protocol, and transformed into E. coli cell line TOP10 (Invitrogen, Carlsbad, CA). A colony was grown overnight, and the pET28-TEV-T4L plasmid was purified using QIAprep Spin Miniprep Kit (Qiagen, Valencia, CA).
T4L and MBP mutants
All mutations in the DNA sequence were performed on the pET28-TEV-T4L or the pMal-a1 (a kind gift from Figure 8 . A scheme summarizing approaches for crystallizing protein targets by rational mutagenesis of surface residues. A protein (red box) can be mutated according to the idea of ''surface entropy reduction" 30 (orange box), which typically involves replacing long flexible amino acid side chains by alanine. Alternatively, or in combination, surface residues can be modified in a way that specifically promotes symmetric oligomerization. This general idea is referred to as ''synthetic symmetrization" 26 ; a closely related idea has been called ''crystal lattice engineering.'' 28 Single cysteine mutations have been used successfully for dimerization 26, 27 (green box). A method based on inserting multiple leucine residues in a surface helix has been used successfully by others (blue box). 28, 32 In this work we propose metal-mediated synthetic symmetrization (purple boxes), which involves introducing either double histidine mutations (lower right box) or double cysteine mutations (lower left box), followed by the addition of metal ions. The metal-mediated approach leads to a rich variety of oligomeric arrangements and crystal packing opportunities. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Prof. Cynthia Wolberger at Johns Hopkins University) plasmids using a Site-Directed Mutagenesis kit (Quick-Change II XL, Agilent, Santa Clara, CA) with sitedirected primers designed using manufacturers Quick-Change Primer Design Program available online (Agilent, Santa Clara, CA), according to the manufacturer's protocol. The final constructs were sequenced prior to transformation into E. coli expression cell line BL21 (DE3) gold cells (Novagen, Gibbstown, NJ).
Protein expression
A single colony was inoculated into LB Miller Broth (Fisher BioReagents, Fisher Scientific, Pittsburgh, PA) supplemented with 30 lg/mL Kanamycin (Fisher Scientific, Pittsburgh, PA; LB Kan ) or 100 lg/mL Ampicillin (Fisher Scientific, Pittsburgh, PA; LB Amp ) for T4L and MBP mutants, respectively. One liter of LB Kan or LB Amp in a 2-L shaker flask was inoculated with 7 mL of overnight culture and grown at 37 C until the culture reached an OD 600 ¼ 0.6-0.8. For T4L mutants, isopropyl b-D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 0.5 mM, and grown for 1.5 h at 37 C. For MBP mutants, IPTG was added to a final concentration of 1 mM, and grown for 4 h at 37 C. Cells were harvested by centrifugation at 5,000g for 10 min at 4 C. The cell pellet was frozen and stored at À80 C prior to purification.
T4L protein purification
The cell pellet was thawed and resuspended in buffer A [50 mM sodium phosphate, 0.3M sodium chloride, and 20 mM imidazole (pH ¼ 8.0)] supplemented with Halt Protease Inhibitor Cocktail (Peirce, Thermo Fisher Scientific, Rockford, IL) and 1 mM DTT for cysteine containing mutants at 25 mL per 1 L of culture volume. The resuspended was culture sonicated and centrifuged at 12,000g for 25 min at 4 C. The clarified lysate was filtered through a 0.45lm syringe filtration device (HPF Millex-HV, catalog no. SLHVM25NS, Millipore, Billerica, MA) before loading onto a 5-mL HisTrap-HP column (GE Healthcare, Piscataway, NJ). The HisTrap-HP column was washed with five column volumes of buffer A and protein eluted with linear gradient to 100% in four column volumes of buffer B [50 mM sodium phosphate, 0.3M sodium chloride, and 500 mM imidazole, (pH ¼ 8.0)]. For cysteine containing mutants, buffers A and B were supplemented with 5 mM beta-mercaptoethanol (BME). Protein eluted around 40-60% buffer B and peak fractions were pooled. TEV protease, produced and purified as described, 36 was added at a volume of 1/100th the pooled volume, and ethylenediaminetetraacetic acid (EDTA) was added to final concentration of 1 mM. After 20-30 min, pooled protein was transferred to a Slide-A-Lyzer 10,000 MWCO dialysis cassette (Pierce, Thermo Fisher Scientific, Rockford, IL), and dialyzed against buffer C (20 mM TRIS pH 8.0, 200 mM sodium chloride, 20 mM imidazole, 1 mM DTT) at room temperature overnight. The dialyzed protein fraction was transferred to a 50 mL conical falcon tube (Fisher Scientific, Pittsburgh, PA). After 2 days of TEV protease cleavage, cut protein was passed over a 5 mL HisTrap HP column pre-equilibrated in buffer A and the flow-through containing His-tag removed T4L was collected and concentrated prior to loading onto a Superdex Prep Grade 75 gel filtration column equilibrated in GF buffer [100 mM sodium chloride, 1 mM DTT, and 20 mM TRIS (pH ¼ 8.0)]. Peak fractions were pooled and concentrated. Protein concentration was determined by UV absorbance at 280 nm with extinction coefficient of 24750 M À1 cm À1 of protein.
MBP protein purification
Cells were resuspended in a lysis buffer containing 100 mM Tris-HCl (pH ¼ 8.0), 100 mM NaCl, and 1 mM EDTA. Phenylmethylsulfonyl fluoride (PMSF) was added to the cell resuspension to a final concentration of 1 mM. Clarified cell lysate, as described above, was loaded onto a self-packed amylose column (150 mL column volume, resin from New England Biolabs, Ipswich, MA). The column was first washed with Buffer A [20 mM Tris-HCl (pH ¼ 8.0) and 100 mM NaCl] for one column volume and then eluted with Buffer B [20 mM Tris-HCl (pH ¼ 8.0), 100 mM NaCl, and 10 mM maltose]. Peak fractions were pooled and concentrated using an Amicon Ultra-15 concentrator (30 kDa MW cutoff; Millipore, Billerica, MA) prior to loading onto a Superdex S-200 column (GE Healthcare, Piscataway, NJ) equilibrated in SEC buffer [20 mM Tris-HCl (pH ¼ 8.0), 100 mM NaCl, and 5 mM maltose]. Peak fractions were pooled and concentrated. Protein concentration was determined by absorbance at 280 nm with the calculated extinction coefficient of 67800 M À1 cm À1 .
Protein crystallization
Concentrated T4L and MBP protein mutants were diluted to $ 1 mM and supplemented with 1.25-1.5 mM of metal: copper sulfate, nickel sulfate, or zinc acetate. Protein solutions containing metals were filtered through a 0.22 lm Ultrafree-MC centrifugal filter device (Amicon, Bedford, MA) prior to crystallization experiments in hanging drop plates. Crystallization experiments were carried out at the UCLA crystallization core facility (http://www.doe-mbi. ucla.edu/facilities/crystallization) and stored at 20 C. The crystallization conditions are provided in Supporting Information Table 3 .
Structure determination
All data were collected at 100 K at Advanced Photon Source (Chicago, IL) beam lines 24-ID-C and 24-ID-E, and in-house on a Rigaku Raxis-IVþþ imaging plate detector using Cu Ka radiation from a Rigaku FREþ rotating anode generator with confocal optics Laganowsky et al. Table 1 ). Single crystals were cryoprotected with glycerol and mounted with CrystalCap HT Cryoloops (Hampton Research, Aliso Viejo, CA). Crystals were flash-cooled in liquid nitrogen prior to data collection. All data were processed using DENZO/SCALEPACK 62 or XDS/XSCALE. 63 Initial phases of T4L and MBP mutants were calculated by molecular replacement using structures with PDB codes 3LZM and 1ANF, respectively, as search models using PHASER. 64 Model building was done using COOT. 65 All model refinement was done using REFMAC, 66 PHENIX, 67 and BUSTER. 68 
(Supporting Information
